Egetis Therapeutics AB (publ) (EGTX) - Total Liabilities

Latest total liabilities as of June 2025: Skr299.30 Million SEK

Based on the latest financial reports, Egetis Therapeutics AB (publ) (EGTX) has total liabilities worth Skr299.30 Million SEK as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Egetis Therapeutics AB (publ) - Total Liabilities Trend (2008–2024)

This chart illustrates how Egetis Therapeutics AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Egetis Therapeutics AB (publ) Competitors by Total Liabilities

The table below lists competitors of Egetis Therapeutics AB (publ) ranked by their total liabilities.

Liability Composition Analysis (2008–2024)

This chart breaks down Egetis Therapeutics AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Egetis Therapeutics AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Egetis Therapeutics AB (publ) (2008–2024)

The table below shows the annual total liabilities of Egetis Therapeutics AB (publ) from 2008 to 2024.